Management of Chemotherapy Induced Thrombocytopenia

Publication Date: October 10, 2023
Last Updated: November 14, 2023

Use of Platelet Transfusion for Severe CIT

We recommend empiric platelet transfusion for platelet count <10 x109 /L
6731

Thrombocytopenia Receptor Agonists for CIT in Solid Tumors

This subcommittee acknowledges the lack of high-quality data (phase 3 trials) demonstrating efficacy for TPO-RA in the management of CIT. As such, any guidance below regarding the use of TPO-RA in management of CIT should be considered suggestions (or weak recommendations).

Overview

Title

Management of Chemotherapy Induced Thrombocytopenia

Authoring Organization